ArticleFrontiers in immunology2022

Immunometabolism characteristics and a potential prognostic risk model associated with TP53 mutations in breast cancer.

Mengping Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.